TAMIFLU Safety Questions, TAMIFLU Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TAMIFLU. Our extensive database of TAMIFLU adverse events and TAMIFLU warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TAMIFLU

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




TAMIFLU Safety Reports

Total TAMIFLU reports: 1065.
TAMIFLU FDA safety alerts: 2003 2006 2007 .
Reported deaths: 116    Reported hospitalizations: 310.
Take TAMIFLU Side Effects Survey or Share Your TAMIFLU Story. TAMIFLU Usage.

Showing 1-75 of 1065 Next >

Physician from JAPAN reported TAMIFLU problem on Feb 22, 2007. Female patient, child 10 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: anxiety, hallucination, vomiting. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 22, 2007. Female patient, child 12 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: diplopia. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 22, 2007. Male patient, 55 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: renal failure. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 22, 2007. Male patient, 36 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: hallucination, nightmare, sleep disorder, suicidal ideation. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 23, 2007. Male patient, child 10 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hallucination. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from UNITED STATES on Mar 02, 2007. Female patient, weighting 60.00 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, hallucination. TAMIFLU dosage: 5 ML BID PO. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 23, 2007. Male patient, 16 years of age, weighting 116.8 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: leukopenia. TAMIFLU dosage: unknown. During the same period patient was treated with CALONAL, SOLITA, PANSPORIN, TANNALBIN, THIATON. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 23, 2007. Male patient, 16 years of age, weighting 143.3 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, disorientation, somnolence. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 23, 2007. Male patient, 15 years of age, weighting 127.9 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, depressed level of consciousness, hallucination, somnolence, vertigo. TAMIFLU dosage: unknown. During the same period patient was treated with MUCOSTA, ZYRTEC, CALONAL, NOLEPTAN. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 26, 2007. Male patient, 13 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. TAMIFLU dosage: unknown. During the same period patient was treated with CALONAL. Patient was hospitalized. Patient recovered.

Pharmacist from JAPAN reported TAMIFLU problem on Feb 28, 2007. Male patient, child 10 years of age, weighting 61.73 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, delirium febrile, encephalopathy. TAMIFLU dosage: unknown. During the same period patient was treated with MUCODYNE, RELENZA. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 27, 2007. Female patient, 15 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: dyspnoea. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 26, 2007. Male patient, 36 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: hallucination, nightmare, sleep disorder, suicidal ideation. TAMIFLU dosage: unknown. During the same period patient was treated with CLARITHROMYCIN, PAXIL, MUCOSOLVAN. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 26, 2007. Male patient, 25 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: diarrhoea. TAMIFLU dosage: unknown. During the same period patient was treated with ZITHROMAC, LOXONIN. Patient died on 02/07/2007.

Physician from FRANCE reported TAMIFLU problem on Feb 27, 2007. Male patient, 72 years of age, was diagnosed with asthma and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: asthmatic crisis. TAMIFLU dosage: unknown. During the same period patient was treated with SEREVENT. Patient died on 02/22/2007.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 27, 2007. Male patient, 21 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. TAMIFLU dosage: unknown. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 28, 2007. Female patient, child 12 years of age, weighting 81.57 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: diplopia. TAMIFLU dosage: unknown. During the same period patient was treated with PEMILASTON, ZESULAN. Patient recovered.

TAMIFLU problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Male patient was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, sleep terror. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 27, 2007. Male patient, child 7 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, depressed level of consciousness. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 27, 2007. Female patient, 28 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, euphoric mood, insomnia, thirst. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 26, 2007. Male patient, 14 years of age, weighting 138.9 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 26, 2007. Male patient, 16 years of age, weighting 99.21 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: delirium. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 28, 2007. Male patient, child 11 years of age, weighting 101.4 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, hallucination, hallucination, auditory, hallucination, visual. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 27, 2007. Female patient, 55 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: cholestasis, delirium, renal impairment. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 27, 2007. Female patient, child 4 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: hypothermia. TAMIFLU dosage: unknown. During the same period patient was treated with FLOMOX, BIOFERMIN R, CALONAL. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 28, 2007. Female patient, 66 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: enterocolitis haemorrhagic. TAMIFLU dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAMIFLU problem on Mar 09, 2007. Male patient, 17 years of age, weighting 150.0 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: dizziness, hallucination, impaired work ability, malaise, neurological examination abnormal, somnolence. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, child 4 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: agitation. TAMIFLU dosage: unknown. During the same period patient was treated with CALONAL. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 01, 2007. Female patient, child 9 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: convulsion, loss of consciousness. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Pharmacist from CANADA on Mar 02, 2007. Female patient, 87 years of age, weighting 130.3 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: influenza, transient ischaemic attack. TAMIFLU dosage: unknown. During the same period patient was treated with ATORVASTATIN, ACETYLSALICYLIC ACID SRT, DOCUSATE, ENALAPRIL MALEATE, METOPROLOL SUCCINATE, VITALUX, NIFEDIPINE. Patient was hospitalized and became disabled. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 01, 2007. Male patient, child 10 years of age, weighting 59.52 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, depressed level of consciousness, dyspnoea. TAMIFLU dosage: unknown. During the same period patient was treated with MUCODYNE, ACDEAM, BISOLVON. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 13 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, delusion, hallucination. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 01, 2007. Male patient, 32 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, confusional state, fall, limb injury, lower limb fracture. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, child 12 years of age, was diagnosed with influenza, cough and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, fall. TAMIFLU dosage: unknown. During the same period patient was treated with MEDICON, POLARAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 28, 2007. Female patient, 93 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: diarrhoea. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 28 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: asthenia, hypoaesthesia, tremor. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 22, 2007. Female patient, 60 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from UNITED STATES on Feb 28, 2007. Female patient, 46 years of age, weighting 132.9 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: amnesia, arrhythmia, blood creatine phosphokinase increased, cardiac enzymes increased, grand mal convulsion, hepatitis alcoholic, hypersensitivity, liver disorder, liver function test abnormal. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 01, 2007. Male patient, child 10 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: delirium febrile. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 01, 2007. Female patient, 24 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: affect lability, delirium. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 02, 2007. Female patient, child 6 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, hallucination. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 02, 2007. Female patient, 40 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: enterocolitis haemorrhagic. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Feb 23, 2007. Female patient, 14 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: brain contusion, fall. TAMIFLU dosage: unknown. Patient died on 02/16/2007.

TAMIFLU problem was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2007. Male patient, 14 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, fall. TAMIFLU dosage: unknown. During the same period patient was treated with CALONAL. Patient died.

Physician from JAPAN reported TAMIFLU problem on Mar 02, 2007. Male patient, 15 years of age, weighting 127.9 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, suicide attempt. TAMIFLU dosage: unknown. During the same period patient was treated with KETEK, MECLOCELIN, ASVERIN, SELBEX. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 02, 2007. Female patient, 14 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: nightmare. TAMIFLU dosage: unknown. Patient recovered.

Physician from UNITED STATES reported TAMIFLU problem on Mar 05, 2007. Male patient, child 11 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, delirium. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Male patient, child 3 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: hallucination. TAMIFLU dosage: unknown. During the same period patient was treated with MOTRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAMIFLU problem on Mar 05, 2007. Male patient, child 10 years of age, weighting 110.0 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: delirium. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, 30 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: leukopenia. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 06, 2007. Female patient, child 11 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: delirium, dyscalculia, hyperacusis, illusion. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, child 10 years of age, weighting 59.52 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, depressed level of consciousness, dyspnoea. TAMIFLU dosage: unknown. During the same period patient was treated with MUCODYNE, ACDEAM, BISOLVON. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 09, 2007. Male patient, child 12 years of age, weighting 112.4 lb, was diagnosed with cough and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, contusion, fall. TAMIFLU dosage: unknown. During the same period patient was treated with MEDICON, POLARAMINE, CALONAL. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, child 4 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: convulsion, depressed level of consciousness, hallucination, headache, somnolence. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 08, 2007. Female patient, 24 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: affect lability, delirium. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, 16 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 01, 2007. Female patient, 13 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: convulsion, loss of consciousness. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, child 4 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 07, 2007. Female patient, 83 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest. TAMIFLU dosage: unknown. During the same period patient was treated with ACETAMINOPHEN. Patient died on 02/28/2007.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 05, 2007. Male patient, child 4 years of age, weighting 28.66 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, depressed level of consciousness, hypertonia. TAMIFLU dosage: unknown. During the same period patient was treated with CALONAL. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 05, 2007. Male patient, 25 years of age, was diagnosed with influenza, infection prophylaxis and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: diarrhoea, myocardial ischaemia. TAMIFLU dosage: unknown. During the same period patient was treated with ZITHROMAC, LOXONIN, FLOMOX. Patient died on 02/07/2007.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 02, 2007. Male patient, weighting 8.38 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: anophthalmos, pregnancy. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 06, 2007. Male patient, 65 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, completed suicide, psychiatric symptom. TAMIFLU dosage: unknown. Patient died on 03/01/2007.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, child 12 years of age, weighting 99.21 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, sleep terror. TAMIFLU dosage: unknown. During the same period patient was treated with CALONAL. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 01, 2007. Female patient, 16 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: confusional state. TAMIFLU dosage: unknown. During the same period patient was treated with RELENZA. Patient recovered.

TAMIFLU problem was reported by a Pharmacist from UNITED STATES on Mar 16, 2007. Male patient, child 12 years of age, weighting 95.00 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: petechiae, rash maculo-papular. TAMIFLU dosage: 75MG Q12H PO. During the same period patient was treated with IBUPROFEN, LORATADINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TAMIFLU problem on Mar 14, 2007. Female patient, 59 years of age, weighting 136.0 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: arrhythmia, balance disorder, dysstasia, fall, hallucination, pneumonia, pruritus. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, 61 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: enterocolitis haemorrhagic. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 09, 2007. Male patient, 16 years of age, weighting 116.8 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: leukopenia. TAMIFLU dosage: unknown. During the same period patient was treated with CALONAL, SOLITA, PANSPORIN, TANNALBIN, THIATON. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 07, 2007. Female patient, child 12 years of age, weighting 81.57 lb, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: diplopia, vision blurred. TAMIFLU dosage: unknown. During the same period patient was treated with PEMILASTON, ZESULAN, MEPTIN, FLOMOX. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 05, 2007. Male patient, weighting 7.28 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, no adverse effect, pregnancy. TAMIFLU dosage: unknown. Patient recovered.

TAMIFLU problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, 26 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: suicide attempt. TAMIFLU dosage: unknown. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 07, 2007. Female patient, 17 years of age, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, urinary incontinence. TAMIFLU dosage: unknown. Patient was hospitalized. Patient recovered.

TAMIFLU problem was reported by a Physician from UNITED STATES on Mar 08, 2007. Female patient, 59 years of age, was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: anaemia, hypersensitivity, hypotension, syncope. TAMIFLU dosage: unknown. During the same period patient was treated with PROCRIT, PREDNISONE, NORVASC. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported TAMIFLU problem on Mar 09, 2007. Male patient, child 11 years of age, weighting 68.34 lb, was diagnosed with influenza and was treated with TAMIFLU. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. TAMIFLU dosage: unknown. Patient recovered.

Showing 1-75 of 1065 Next >

Ask Our Patient Community about TAMIFLU

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine

QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase
(prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
RazadyneThis drug has as active FDA Safety Alert (galantamine)
Rebetol (ribavirin)
ReclastThis drug has as active FDA Safety Alert (zoledronic acid)
Refludan (lepirudin recombinant)
Relenza (zanamivir)
RelpaxThis drug has as active FDA Safety Alert (eletriptan)
RemeronThis drug has as active FDA Safety Alert (mirtazapine)
Renagel (sevelamer)
Rescula (unoprostone isopropyl)
Restoril (temazepam)
Revatio (sildenafil)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Ribasphere (ribavarin ribasphere)
Ribavarin ribasphere
Rifapentine
Rifaximin
RisedronateThis drug has as active FDA Safety Alert
Risperdal (risperidone)
Risperidone
Ritalin (methylphenidate)
Ritonavir
RituxanThis drug has as active FDA Safety Alert